NCT03840811
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Communicable Diseases, +9 more
- Locations
-
- University of North Carolina Health Care - Infectious Diseases Chapel Hill, North Carolina, United States
Clinical trial condition
Neisseriaceae Infections
Explore clinical trials studying Neisseriaceae Infections. Study availability and eligibility vary by location and protocol.
400 public trials
21 recruiting studies
Neisseriaceae Infections trial results
Completed
Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612
NCT00955682
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Espoo, Finland
- GSK Investigational Site Helsinki, Finland
- GSK Investigational Site Helsinki, Finland
- GSK Investigational Site Jarvenpaa, Finland
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
- Locations
-
- GSK Investigational Site Salvador, Estado de Bahia, Brazil
- GSK Investigational Site Natal, Rio Grande do Norte, Brazil
- GSK Investigational Site Rio de Janeiro, Brazil
- GSK Investigational Site São Paulo, Brazil
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Blacktown, New South Wales, Australia
- GSK Investigational Site Kanwal, New South Wales, Australia
- GSK Investigational Site Gold Coast, Queensland, Australia
- GSK Investigational Site Sherwood, Queensland, Australia
Completed
Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba)
NCT02569632
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +3 more
- Locations
-
- UCSF Benioff Children's Hospital Oakland Oakland, California, United States
- University of Massachusetts Medical School Worcester, Massachusetts, United States
NCT03824093
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
- Locations
-
- Children's Mercy Hospital Kansas City Kansas City, Missouri, United States
NCT01144663
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Haabneeme, Estonia
- GSK Investigational Site Tallinn, Estonia
- GSK Investigational Site Tallinn, Estonia
- GSK Investigational Site Tallinn, Estonia
NCT03125616
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Female Urogenital Diseases and Pregnancy Complications, +12 more
- Locations
-
- St Georges University Hospital NHS Foundation Trust Tooting, London, United Kingdom
NCT01266993
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Draguignan, France
- GSK Investigational Site Le Havre, France
- GSK Investigational Site Lingolsheim, France
- GSK Investigational Site Miribel, France
Completed
Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects
NCT00514904
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Goā, India
- GSK Investigational Site Indore, India
- GSK Investigational Site New Delhi, India
- GSK Investigational Site Vellore, India